Global Financial Private Client’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
12,160
+2,072
+21% +$273K 0.42% 70
2026
Q1
$1.41M Buy
10,088
+1,671
+20% +$234K 0.46% 60
2025
Q4
$1.03M Buy
8,417
+261
+3% +$31.7K 0.36% 83
2025
Q3
$905K Buy
8,156
+330
+4% +$37.5K 0.32% 91
2025
Q2
$868K Buy
7,826
+305
+4% +$32.5K 0.33% 85
2025
Q1
$843K Buy
7,521
+1,453
+24% +$150K 0.32% 88
2024
Q4
$561K Buy
6,068
+5,609
+1,222% +$505K 0.21% 121
2024
Q3
$38.5K Buy
459
+292
+175% +$22.3K 0.02% 341
2024
Q2
$11.5K Sell
167
-150
-47% -$10K ﹤0.01% 434
2024
Q1
$23.1K Hold
317
0.01% 384
2023
Q4
$25.7K Hold
317
0.01% 364
2023
Q3
$23.5K Sell
317
-4,605
-94% -$354K 0.01% 359
2023
Q2
$378K Buy
4,922
+291
+6% +$23.2K 0.19% 126
2023
Q1
$385K Sell
4,631
-96
-2% -$7.95K 0.2% 111
2022
Q4
$406K Buy
4,727
+135
+3% +$10.7K 0.23% 95
2022
Q3
$286K Buy
4,592
+4,275
+1,349% +$270K 0.16% 114
2022
Q2
$19.8K Buy
317
+80
+34% +$4.95K 0.01% 348
2022
Q1
$14.1K Hold
237
0.01% 371
2021
Q4
$17.2K Hold
237
0.01% 348
2021
Q3
$16.2K Hold
237
0.01% 314
2021
Q2
$16.4K Hold
237
0.01% 315
2021
Q1
$15.7K Hold
237
0.01% 285
2020
Q4
$13.8K Sell
237
-150
-39% -$9.05K 0.01% 291
2020
Q3
$24.5K Buy
387
+134
+53% +$9.29K 0.02% 244
2020
Q2
$19.2K Sell
253
-325
-56% -$24.9K 0.02% 299
2020
Q1
$41.9K Buy
578
+48
+9% +$3.32K 0.04% 226
2019
Q4
$34.4K Buy
+530
New +$34.5K 0.03% 283

Other funds holding GILD

Global Financial Private Client's GILD Position: Q2 2026 in Review

Global Financial Private Client increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $273K and bringing the position to 12,160 shares worth $1.54M. The position accounts for 0.42% of the portfolio, ranked #70.

Global Financial Private Client first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Global Financial Private Client held 12,160 shares of Gilead Sciences worth $1.54M as of Q2 2026.
  • Global Financial Private Client bought 2,072 Gilead Sciences shares in Q2 2026, an estimated $273K.
  • Gilead Sciences made up 0.42% of Global Financial Private Client's portfolio in Q2 2026, its #70 holding.
  • Global Financial Private Client first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Global Financial Private Client's 13F filing for Q2 2026, filed 20 Jul 2026.